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ABSTRACT 
 
 
Purpose: To evaluate the independent and combined associations of 
cardiorespiratory fitness (CRF) and muscular strength (MS) with arterial stiffness (AS) in 
older adults. 
Methods: This cross-sectional study included 427 older adults aged ≥65 years (mean age 
72). CRF was assessed by time (seconds) to complete a 400-m walk test and MS by 
overall grip strength (maximum out of 3 trials on each hand, averaged; Jamar Plus+ 12-
064). Carotid-femoral pulse wave velocity (PWV) was used to assess AS (AtCor, 
Sphygmocor Xcel). High AS was defined as a PWV of 10 m/s or greater, as it has been 
established as a threshold for increased cardiovascular risk. Logistic regression was used 
to calculate odds ratios (ORs) and 95% confidence intervals (95% CIs) of having high AS 
across sex-specific tertiles of CRF and MS. Linear and logistic regression were used to 
investigate the independent associations between CRF or MS with AS. Further, CRF and 
MS were dichotomized into either weak or unfit (lower one-third for each), or strong or 
fit (upper two-thirds for each) to investigate the combined associations of CRF and MS 
with high AS.  
Results: Sixty-three (17 %) adults were identified as having high AS. In logistic 
regression, compared to lower CRF (lowest 33%), ORs (95% CIs) of having high AS 
were 0.44 (0.23-0.85) and 0.46 (0.25-0.94) for middle and upper CRF, respectively, after 
controlling for age and sex. After further adjustment for mean arterial pressure (MAP) 
and lifestyle factors, only middle CRF remained significant (OR, 0.48 [95% CI 0.25-
0.94]). Compared to lower MS (lowest 33%), ORs (95% CIs) of having high AS were 
0.40 (0.20-0.80), 0.32 (0.15-0.70), and 0.34 (0.15-0.77) for upper MS, after adjustment 
viii 
 
for age and sex, further for MAP and lifestyle factors, and further for CRF, respectively. 
In the joint analysis, compared to Unfit & Weak, ORs (95% CIs) of having high AS were 
0.32 (0.13-0.80), 0.35 (0.13-0.93), and 0.27 (0.12-0.60) for Unfit & Strong, Fit & Weak, 
and Fit & Strong groups, respectively. 
Conclusion: Higher levels of both CRF and MS appeared to be associated with a lower 
prevalence of increased (high) arterial stiffness in older adults.  
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CHAPTER 1.    INTRODUCTION 
 
More than one in three adults in the United States have cardiovascular disease 
(CVD), and it is the leading cause of death for both men and women. Over half of the 
adults with CVD are 65 years or older, and almost two-thirds of CVD deaths in the 
United States occur among adults 75 years or older (Older Americans & Cardiovascular 
Diseases, 2016). Due to age-related changes in the structure and function of the 
cardiovascular system, CVD in older adults often goes undetected by clinical signs and 
symptoms (Jakovljevic, 2017). Additionally, traditional CVD risk factors such as 
peripheral blood pressure, diabetes mellitus, cholesterol, smoking, and obesity have been 
studied in predominantly middle-age populations, resulting in less effective prediction of 
incident CVD in older populations (Lind, Sundström, Ärnlöv, & Lampa, 2018). Since the 
proportion of older adults in the world population is predicted to increase from 12% to 
22% between 2015 and 2050, better understanding of the risk factors in older adults is 
even more important for the prevention and treatment of CVD (“Ageing and health,” 
2018).  
Compared to veins, arteries are not considered compliant. However, the elastic 
component of arteries plays a key role in reducing the pressure in them, making arterial 
stiffness an emerging CVD risk factor. Research shows it to be a strong, independent 
predictor of cardiovascular outcomes (Avolio, 2013; Ben-Shlomo et al., 2014; Fagard et 
al., 2007; Sutton-Tyrrell et al., 2005; Van Bortel et al., 2012; Vlachopoulos, Aznaouridis, 
& Stefanadis, 2010; Zheng et al., 2015). Arterial stiffness is due to the structural and 
cellular changes to arteries, which are thought to result from aging and many diseased 
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states (obesity, diabetes, insulin resistance, dyslipidemia, and hypertension, etc.) 
(Boreham et al., 2004; Braith & Stewart, 2006; H.-Y. Lee & Oh, 2010; Zieman, 
Melenovsky, & Kass, 2005). As arteries stiffen in older adults, blood travels faster 
through them due to the decreased elasticity. The increased speed of the pressure wave 
leaving the heart, and subsequently the wave reflected back from the peripheries reaches 
the heart during systole, rather than diastole (Ben-Shlomo et al., 2014; Fagard et al., 
2007; Van Bortel et al., 2012). This process is thought to be the cause of isolated systolic 
hypertension, which is especially prevalent in older adults (Fagard et al., 2007; Shirwany 
& Zou, 2010; Zieman et al., 2005). However, age-related increases in arterial stiffness are 
also seen in healthy populations (Tanaka, Desouza, & Seals, 1998; Vaitkevicius, Fleg, 
Engel, O’connor, et al., 1993). 
Higher levels of physical activity are associated with lower arterial stiffness in 
older adults (Endes et al., 2016; Park, Park, Lim, & Park, 2017; Shibata et al., 2018). 
However, these studies, like many others, use questionnaires to assess physical activity. 
These subjective forms of assessment typically overestimate actual physical activity, are 
unable to take into account activities of daily living, and often do not assess muscle 
strengthening activities, flexibility exercises, or weight-bearing activities (Manini et al., 
2006; Sallis & Saelens, 2000). To combat this, objective measures of physical fitness 
(cardiorespiratory fitness and muscular strength) can be used to represent the effects of 
recent habitual physical activity (D. Lee, Artero, Sui, & Blair, 2010; Mozaffarian et al., 
2015). 
The purpose of this study is to investigate the independent and combined 
associations of cardiorespiratory fitness and muscular strength with arterial stiffness in 
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older adults using a prospective cohort, Physical Activity and Aging Study (PAAS), data 
collected since 2015 at Iowa State University Physical Activity Epidemiology Lab.  
Specific aims 
Aim 1: To determine the associations between cardiorespiratory fitness and arterial 
stiffness, independent of muscular strength, in older adults. 
Null Hypothesis: Cardiorespiratory fitness will not be associated with arterial stiffness, 
independent of muscular strength, in older adults. 
Alternative Hypothesis: Higher cardiorespiratory fitness will be associated with lower 
arterial stiffness, independent of muscular strength. 
Aim 2: To determine the associations between muscular strength and arterial stiffness, 
independent of cardiorespiratory fitness, in older adults. 
Null Hypothesis: Muscular strength will not be associated with arterial stiffness, 
independent of cardiorespiratory fitness, in older adults. 
Alternative Hypothesis: Higher muscular strength will be associated with lower arterial 
stiffness, independent of cardiorespiratory fitness. 
Aim 3: To determine the combined associations of cardiorespiratory fitness and muscular 
strength with arterial stiffness in older adults.  
Null Hypothesis: The combined association of cardiorespiratory fitness and muscular 
strength with arterial stiffness will not be stronger than either cardiorespiratory fitness or 
muscular strength alone. 
Alternative Hypothesis: The combined association of cardiorespiratory fitness and 
muscular strength with arterial stiffness will be stronger than either cardiorespiratory 
fitness or muscular strength alone.  
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CHAPTER 2.   REVIEW OF LITERATURE 
 
 This literature review will cover 1) cardiovascular disease (CVD) in relation to 
arterial stiffness (AS), cardiorespiratory fitness (CRF), and muscular strength (MS), 2) 
the mechanisms of AS reduction, and 3) the magnitude of AS reduction across different 
levels of CRF and MS. 
 
Cardiovascular Disease  
Arterial stiffness 
Arterial stiffness is the reduction in the compliance and distensibility of the large 
central arteries, and it is associated with the presence of CVD risk factors, vascular 
dysfunction, and inflammatory and metabolic diseased states (Alvim et al., 2017; Kohn, 
Lampi, & Reinhart-King, 2015; Niiranen et al., 2016; Stehouwer, Henry, & Ferreira, 
2008; van Sloten, 2017; Charalambos Vlachopoulos et al., 2010). More importantly, AS 
is an independent predictor of future hypertension, CVD events, CVD mortality, and all-
cause mortality, in adults and older adult populations (Avolio, 2013; Ben-Shlomo et al., 
2014; Fagard et al., 2007; Mitchell et al., 2010; Niiranen et al., 2016; Sutton-Tyrrell et 
al., 2005; Van Bortel et al., 2012; Vlachopoulos et al., 2010; Zheng et al., 2015). AS is 
thought to result from accumulated damage done to artery walls due to aging, smoking, 
lipid metabolism, and other risk factors, and relates to CVD risk independent of 
traditional risk factors (Ben-Shlomo et al., 2014; Zhu et al., 2014). 
Pulse wave velocity (PWV) is the gold standard for assessing arterial stiffness 
(Ben-Shlomo et al., 2014; Fagard et al., 2007; Van Bortel et al., 2012). PWV measures 
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the speed of the pressure wave that travels from the left ventricle of the heart through the 
arteries (Butlin & Qasem, 2017). As arteries stiffen, the pressure wave travels faster; high 
PWV reflects high AS. A faster PWV disrupts the natural timing of the cardiac cycle, 
causing the wave reflected back from the peripheries to reach the heart during systole, 
rather than diastole (Ben-Shlomo et al., 2014; Fagard et al., 2007; Van Bortel et al., 
2012). This increases the afterload on the left ventricle and reduces coronary perfusion 
pressure, resulting in increased central pulse pressure and isolated systolic hypertension 
(Alvim et al., 2017; Butlin & Qasem, 2017). These pressure changes can contribute to left 
ventricle hypertrophy, coronary ischemia, and increased stress on the entire 
cardiovascular system, increasing the risk of adverse CVD events (Alvim et al., 2017; 
Butlin & Qasem, 2017; Zieman et al., 2005).  
For every 1 meter/second increase in PWV, there is a 7-14% increased risk for a 
CVD event and a 15% increased risk for both CVD and all-cause mortalities (Ben-
Shlomo et al., 2014; Vlachopoulos et al., 2010). When comparing high and low AS, the 
risk of CVD events, CVD mortality, and all-cause mortality nearly doubles for people 
Figure 1. Pooled Risk Ratios (RRs) and 95% Confidence Intervals (CI) for PWV and (A) total CV 
events, (B) CV mortality, (C) total mortality, by baseline risk (due to diseased state). From 
Vlachopoulos et al. 2010 
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with a higher PWV (RR[95% CI]: 2.26[1.89, 2.70], 2.02[1.68, 2.42], and 1.90[1.61, 
2.24], respectively) (Charalambos Vlachopoulos et al., 2010) (See Figure 1). When this 
systematic review and meta-analysis was conducted, there was no defined cut-off point 
for high PWV. The cut-off point for high PWV used in analysis was inconsistent, ranging 
from >8.2 m/s to >17.7 m/s (Charalambos Vlachopoulos et al., 2010). Since then, the 
European Society of Hypertension Working Group on Vascular Structure and Function 
and the European Network for Noninvasive Investigation of Large Arteries advices 10 
m/s as the cut-off for high PWV (Van Bortel et al., 2012). 
 Additionally, in the previously mentioned meta-analysis, only half of the studies 
were from the general population, while the other half were clinical (hypertensive, 
diabetic, chest pain, or end stage renal disease) populations (Charalambos Vlachopoulos 
et al., 2010). To address this, they conducted a population-specific analysis and found 
that AS is a stronger predictor of adverse cardiovascular events in populations with 
increased risk of CVD due to underlying disease, such as coronary artery disease, renal 
disease, hypertension, and diabetes, compared to the general population (Ben-Shlomo et 
al., 2014; Niiranen et al., 2016; Vlachopoulos et al., 2010) (See Figure 1).  
AS remains an independent predictor after adjustment for traditional CVD risk 
factors, in both hypertensive and general populations. (Ben-Shlomo et al., 2014; Hansen 
et al., 2006; Mitchell et al., 2010; Niiranen et al., 2016; Vlachopoulos et al., 2010). In 
middle-aged and older adults, PWV was a stronger predictor of cardiovascular mortality, 
coronary heart disease, and stroke, compared to 24-hour mean arterial pressure or 
traditional CVD risk factors (Hansen et al., 2006). However, office and 24-hour pulse 
pressures, as well as PWV were all significant predictors of CVD events and mortality in 
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sex- and age-adjusted models. But unlike PWV, neither office nor 24-hour pulse 
pressures remained significant in the fully adjusted model (age, sex, body mass index, 
mean arterial pressure, current smoking, and alcohol intake) (Hansen et al., 2006).  
PWV also strengthens CVD risk prediction when added to traditional risk factors 
(Ben-Shlomo et al., 2014; Mitchell et al., 2010; Vlachopoulos et al., 2010). When 
evaluating model performance, a basic model (age and sex) with PWV performed 
comparably to the fully-adjusted model that included all of the standard risk factors 
(Mitchell et al., 2010). This suggests that AS provides unique predictive insight that may 
not be detected by traditional risk factors.  
AS may be a strong indicator of cardiovascular health because it provides insight 
into the cumulative damage to arterial walls, which is difficult to determine with 
traditional CVD risk factors (Charalambos Vlachopoulos et al., 2010). For example, 
blood pressure does not always reflect the stress on the cardiovascular system due to 
increased artery stiffness (Mitchell et al., 2010), since patients with well-treated 
hypertension still have high PWV. Thus, despite reductions in peripheral blood pressure, 
the persistently increased AS is associated with a higher risk of CVD events (Niiranen et 
al., 2016). This could explain the residual risk of CVD that remains even in well-
controlled hypertension, demonstrating one potential mechanism contributing to the 
independent predictive power of AS (Niiranen et al., 2016). 
A consistent theme throughout the above references is that AS is a strong 
predictor of CVD morbidity and mortality, independent of traditional risk factors and in 
many different populations. 
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Cardiorespiratory fitness 
 Across many populations and age ranges, CRF is independently associated with 
longevity and is a stronger predictor of mortality than smoking, hypertension, high 
cholesterol, and type 2 diabetes (Kaminsky et al., 2013; Kodama et al., 2009; D.-C. Lee 
et al., 2012; D. C. Lee et al., 2011; McAuley, Pittsley, Myers, Abella, & Froelicher, 2009; 
Ross et al., 2016; Sui, Laditka, Hardin, & Blair, 2007; Zhu et al., 2014). CRF is also 
inversely associated with CVD risk factors, CVD events, and CVD mortality (Kodama et 
al., 2009; D. C. Lee et al., 2011; Ross et al., 2016; Sui, LaMonte, & Blair, 2007; Zhu et 
al., 2014). The majority of these CVD-focused studies were conducted in middle-aged 
populations. Since traditional CVD risk factors and CRF are impacted by age, it is 
important to understand how the relationship between CRF and cardiovascular health 
may differ in older populations (Sandbakk et al., 2016). 
The inverse association between CRF and CVD health outcomes is also seen in 
older adults (Kokkinos et al., 2017; Sandbakk et al., 2016; Sui, Laditka, et al., 2007). In 
contrast to traditional risk factors and CVD mortality, the relationship between CRF and 
CVD mortality is often stronger with age (Berry et al., 2011; Sui, Laditka, et al., 2007). 
When comparing the lifetime risk of cardiovascular mortality, risk increased with each 
age group: 45 years, 55 years, and 65 years. 
Additionally, when comparing the risks between fitness 
levels (low and high), the low fitness group increased 
much more with each advance in age group (45 years: 
14% and 3%; 55 years: 34% and 15%; 65 years: 36% 
and 17%) (Berry et al., 2011). In another study, for 
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Figure 2. Lifetime risk for CVD 
death by age group and fitness level. 
Low = quintile 1; High = quintiles 
4&5. Adapted from Berry et al. 
2011 
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every 1-MET increase in estimated CRF, there was a 10% (95% CI 0.85-0.96), 22% 
(95% CI 0.60-0.80), and 67% (95% CI 0.12-0.92) reduced risk of CVD mortality for 
adults 60-69, 70-79, and 80 years old, respectively (Sui, Laditka, et al., 2007). Both of the 
previous studies used objective measures of CRF, which are preferred, but with older 
adults the risk of selection bias has to be considered. If only healthier older adults 
complete the fitness test, the results could be skewed as they may also be a generally 
healthier portion of the population.   
Walking tests, like the 400-meter walk and the long-distance corridor walk test 
(LDCW), push older adults close to their maximum aerobic capacity and have been 
shown to strongly relate to oxygen consumption (Georgiopoulou et al., 2017; Anne B. 
Newman et al., 2006; Pettee Gabriel et al., 2010; Simonsick, Fan, & Fleg, 2006). 
Specifically in healthy adults ranging from 60-91 years old, time to complete the 400-
meter walk was correlated with measured peak VO2 (r = -0.79) (Simonsick et al., 2006). 
Because of the simplicity and safety of these tests, they are commonly used as surrogate 
measures of CRF in older adults who may not be able to complete other CRF tests with 
complex protocols (Georgiopoulou et al., 2017). In addition to predicting functional 
limitation and disability, walking tests are predictive of CVD events and all-cause 
mortality (Georgiopoulou et al., 2017; Anne B. Newman et al., 2006; Vestergaard, Patel, 
Bandinelli, Ferrucci, & Guralnik, 2009). In a population of community-dwelling older 
adults, each additional minute to complete the 400-meter walk was associated with a 20% 
increase in CVD incidence (95% CI 1.01-1.42) and 29% increase in mortality (95% CI 
1.12-1.48) (Anne B. Newman et al., 2006). 
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 Similar to arterial stiffness, CRF gives insight into the current physiologic state of 
the body, including the health and functional status of the muscular, cardiovascular, and 
respiratory organ systems. Additionally, it takes into account recent physical activity 
level and the genetic and nutritional factors that also influence CRF (D. Lee et al., 2010; 
Mozaffarian et al. , 2015; Vaitkevicius, Fleg, Engel, O’Connor, et al., 1993). As 
previously mentioned, CRF consistently demonstrates a strong relationship with 
longevity and CV-specific risk and mortality. Even though it does decline with age, 
maintenance and improvement of CRF is possible, making it an important factor in the 
prevention and treatment of CVD.  
 
 Muscular strength 
The metabolic components of muscle tissue link it to obesity, insulin resistance, 
type two diabetes, dyslipidemia, and hypertension, which are all conditions that 
ultimately lead to increased risk of CVD and other chronic diseases (Artero et al., 2011; 
Braith & Stewart, 2006; Wolfe, 2006). MS has been shown to be independently 
associated with many CVD risk factors, including weight and adiposity gains, incident 
hypertension (in pre-hypertensives), and metabolic syndrome (Artero et al., 2011; 
Maslow, Sui, Colabianchi, Hussey, & Blair, 2010).  
In addition to CVD risk factors, MS is also inversely related to CVD-specific 
health outcomes, but this protective effect is partially explained by CRF (Åberg et al., 
2015; Ruiz et al., 2008; Timpka, Petersson, Zhou, & Englund, 2014; Vaara, 2014). For 
instance, low MS as an adolescent was associated with increased risk of all-cause and 
CVD mortality in middle age, and high MS with a lower risk of future CVD events. After 
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controlling for CRF, the relationships between MS and CVD health outcomes were 
attenuated, but largely remained significant (only low MS and CVD mortality was no 
longer significant) (Åberg et al., 2015; Silventoinen, Magnusson, Tynelius, Batty, & 
Rasmussen, 2009; Timpka et al., 2014). 
Many of these studies only included young 
men and a few included data collected from 
young men at military training, limiting the 
generalizability of the results.  
Grip strength is commonly used as 
an indicator of MS, and often to stratify risk 
based on MS (Kozakai, 2017; Leong et al., 
2015). A clear association between MS and longevity has been established using grip 
strength (Karlsen, Nauman, Dalen, Langhammer, & Wisløff, 2017; Leong et al., 2015; 
Ling et al., 2010; Prasitsiriphon & Pothisiri, 2018; Sasaki, Kasagi, Yamada, & Fujita, 
2007). Grip strength is also associated with cardiometabolic risk, blood pressure, blood 
lipids, fasting glucose, metabolic syndrome, stroke and coronary heart disease, like other 
measures of MS (1 repetition maximum, isometric contractions, etc.) (WJ Lee, Peng, 
Chiou, & Chen, 2016; Silventoinen et al., 2009). Across many countries and age ranges, 
for every 1-standard deviation decrease in grip strength, there was a 37% (95% CI 1.28-
1.47), 45% (95% CI 1.30-1.63), and 39% (95% CI 1.32-1.47) increased risk of all-cause 
mortality, CVD mortality, and CVD risk, respectively (Leong et al., 2015).  
Grip strength is a simple and low-risk assessment, making it an appealing and 
frequently used measure of strength in older adult populations. In older women, low grip 
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Figure 3. Increased risk (hazard ratio) for 
every 1-standard deviation decrease in grip 
strength, in adults 35-70 years old. Adapted 
from Leong et al. 2015 
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strength was associated with a 39% (CI 95% 1.05-1.85) and 57% (CI 95% 1.01-2.42) 
increased risk of all-cause and CVD mortality, respectively (Karlsen et al., 2017). 
Similarly, when comparing the lowest strength quintile to the middle (3rd) quintile, there 
was a 38% (95% CI 1.01-1.88) and 54% (95% CI 1.20-1.98) increased risk of all-cause 
mortality, in men and women 65-74 years old, respectively (Sasaki et al., 2007). Grip 
strength is associated with all-cause and CVD mortality, and is consistently a stronger 
predictor of the latter in older adults (Karlsen et al., 2017; Ling et al., 2010; 
Prasitsiriphon & Pothisiri, 2018; Sasaki et al., 2007). 
 In summary, MS, measured a variety of ways, has a protective association with 
cardiovascular health, independent of CRF. While not as widely accepted as CRF, MS is 
another indicator of cardiovascular health that can be used in the prevention and 
treatment of CVD. 
 
Mechanisms of Arterial Stiffness Reduction 
Age is the strongest determinant of AS (Sethi, Rivera, Oliveros, & Chilton, 2014; 
Shirwany & Zou, 2010; Vaitkevicius, Fleg, Engel, O’Connor, et al., 1993). Obesity, 
diabetes, insulin resistance, dyslipidemia, and hypertension have all been determined risk 
factors of AS, as they accelerate vascular aging (Boreham et al., 2004; Braith & Stewart, 
2006; H.-Y. Lee & Oh, 2010). The previously listed diseases, along with other conditions 
that cause disruptions in hemodynamics, hormones, and inflammation, alter the structure 
and function of the arterial wall (Alvim et al., 2017; Kohn et al., 2015; Quinn, 
Tomlinson, & Cockcroft, 2012). These alterations include calcification, changes in the 
extracellular matrix (balance of elastin and collagen and irreversible cross-links of 
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proteins), vascular smooth muscle hypertrophy, and endothelial dysfunction (Alvim et al., 
2017; Kohn et al., 2015; Quinn et al., 2012). 
Treatments to reduce AS include: pharmacological interventions, exercise 
training, weight loss, and dietary and other lifestyle modifications (H.-Y. Lee & Oh, 
2010). Exercise training (aerobic and resistance) often results in improvements in aerobic 
capacity (CRF), MS, body composition, and metabolic markers (Laukkanen et al., 2009; 
Vaitkevicius, Fleg, Engel, O’connor, et al., 1993; Williams et al., 2007). Some factors of 
arterial stiffening, like calcification, fracture of elastic fibers, cross-linking of proteins, 
and genetics may not be reversible, but exercise training can slow down their effects on 
AS (Yuko Gando et al., 
2016; H.-Y. Lee & Oh, 
2010; Niiranen et al., 
2016; Vaitkevicius, Fleg, 
Engel, O’Connor, et al., 
1993). Additionally, 
exercise has been shown 
to improve endothelial dysfunction, autonomic imbalance, oxidative stress, peripheral 
blood pressure, insulin sensitivity, blood lipid profile, inflammation, and body 
composition which have all been shown to effect AS (D. Lee et al., 2010; Leong et al., 
2015; Parise, Brose, & Tarnopolsky, 2005; Vincent, Vincent, Braith, Lennon, & 
Lowenthal, 2002).  
Figure 4. Summary of the major mechanisms of arterial stiffening. From 
Alvin et al. 2017 
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 Since age is the strongest determinant of AS, treatments that can target reductions 
in vascular aging could be the most beneficial (Sethi et al., 2014; Shirwany & Zou, 2010; 
Vaitkevicius, Fleg, Engel, O’Connor, et al., 1993). Aerobic and resistance exercise, often 
reflected by higher CRF and MS, provide potential mechanisms that facilitate AS 
reduction (D. Lee et al., 2010; Leong et al., 2015; Parise et al., 2005; Vincent et al., 
2002). Both aerobic and resistance 
exercise have been shown to improve 
traditional CVD risk factors, which are 
related to AS. Although, as previously 
mentioned, AS is related to CVD risk 
independently of the traditional risk factors 
(see Figure 5), suggesting that exercise 
directly affects the structure and function 
of arteries. Only aerobic training appears 
to be associated with improvements in 
structural components of arteries (Ferreira, Boreham, & Stehouwer, 2006). Over time, the 
elevated blood pressure that occurs during resistance training may actually influence the 
amount of vascular smooth muscle, collagen, and elastin fibers, resulting in increased AS 
(Tanaka & Safar, 2005). However, both aerobic and resistance exercise are associated 
with improvements in functional components of arteries (i.e. endothelial function, 
inflammation, and sympathetic activity, etc.) that contribute to reductions in AS (Ferreira 
et al., 2006). While not as thoroughly studied as aerobic training, resistance training 
Figure 5. Mode of exercise on health and fitness 
variables (Braith & Stewart, 2006) 
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contributes metabolic (improved insulin response and increased basal metabolic rate) and 
hormonal benefits that may influence AS (Artero et al., 2012; Braith & Stewart, 2006).  
Many of the diseases and conditions that advance vascular aging are also 
positively influenced by exercise (D. Lee et al., 2010). CRF and MS are not only 
indicators of exercise and physical activity, but also reflective of lifestyle and genetic 
factors that influence overall health (Vaitkevicius, Fleg, Engel, O’Connor, et al., 1993). 
Better understanding of the magnitude of the associations between CRF, MS and AS, 
independently and in combination, could help determine the optimal approach to 
preventing and treating modifiable CVD risk factors.  
 
Associations between Cardiorespiratory Fitness, Muscular Strength, and Arterial 
Stiffness 
 
 
 
Cardiorespiratory fitness 
 
AS and CRF are both strongly associated with cardiovascular health, so it is 
beneficial to understand their relationship with each other. There are many determinants 
of CRF (aerobic exercise, physical activity, diet, genetics, etc.), but CRF primarily 
reflects recent aerobic exercise. Aerobic training intervention studies consistently report 
reductions in AS, suggesting that CRF may reflect this also (Ashor, Lara, Siervo, Celis-
Morales, & Mathers, 2014).  
There is an inverse relationship between CRF and AS (Arena, Fei, Arrowood, & 
Kraft, 2007; Boreham et al., 2004; Y. Gando et al., 2010; Hunter et al., 2014; Jae et al., 
2010; Königstein et al., 2018; Vaitkevicius, Fleg, Engel, O’Connor, et al., 1993; Zhu et 
al., 2014). This relationship exists in a variety of populations, including those that are 
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predisposed to increased arterial stiffness, such as African Americans, people with 
metabolic syndrome, or overweight/obese individuals (Arena et al., 2007; Boreham et al., 
2004; Jae et al., 2010; Königstein et al., 2018).  
The relationship between CRF and AS has also been examined across different 
age groups. While studies in young adults provide mixed results, the relationship 
becomes more clearly defined with age (Boreham et al., 2004; Namgoong, Lee, Hwang, 
& Lee, 2018; Tanaka et al., 1998; Vaitkevicius, Fleg, Engel, O’Connor, et al., 1993). In a 
study that included both middle-aged and 
older women, CRF explained 41% of the 
variation in AS (p<.0001), independent of 
their self-reported physical activity levels 
(r=-0.5 to -0.7) (Tanaka et al., 1998). 
Similarly, in a study of young and old 
women, AS increased with age regardless of fitness level (p<0.01); however, AS differed 
between fitness levels only among the older women (p<0.01) (Y. Gando et al., 2010). 
Suggesting, high CRF is associated with less age-related arterial stiffening in older 
women. When a population of healthy men was split into young (20-44 years), middle 
(45-70 years), and older (70+ years) adults, increases in CRF were only associated with 
decreased AS in the oldest group (r=0.52, p<0.02) (Vaitkevicius, Fleg, Engel, O’Connor, 
et al., 1993). To further investigate CRF and age-related AS, senior athletes were 
compared to both young and old sedentary adults. The senior athletes had a PWV 26% 
lower than the age-matched sedentary adults, and there was no significant difference 
between the AS of the young sedentary and senior athletes (Vaitkevicius, Fleg, Engel, 
Figure 6. PWV of young and old men, according to 
activity level. *old sedentary differs from young sedentary 
and old athletes at P<.0001 
17 
 
O’Connor, et al., 1993). All of these cross-sectional studies demonstrate that higher levels 
of CRF are associated with less age-related AS (Ferreira et al., 2005; Y. Gando et al., 
2010; Tanaka et al., 1998; Vaitkevicius, Fleg, Engel, O’Connor, et al., 1993). Since age is 
the strongest determinant of AS, it is valuable to specifically examine how CRF 
influences AS over time.  
Gando and colleagues (2016) examined the association of CRF and age-related 
AS over a 2 year follow-up (Yuko Gando et al., 2016). CRF was independently 
associated with AS, and the lowest CRF tertile had a larger 2-year increase in AS than 
highest tertile (p=0.024). There is consistent evidence that higher CRF is associated with 
lower age-related AS (Ferreira et al., 2005; Y. Gando et al., 2010; Tanaka et al., 1998; 
Vaitkevicius, Fleg, Engel, O’Connor, et al., 1993).  
 Higher levels of CRF are consistently associated reduced AS, and in a variety of 
populations generally predisposed to increased AS (Arena et al., 2007; Boreham et al., 
2004; Y. Gando et al., 2010; Hunter et al., 2014; Jae et al., 2010; Königstein et al., 2018; 
Vaitkevicius, Fleg, Engel, O’Connor, et al., 1993; Zhu et al., 2014). However, most 
studies do not take into account MS. Since MS is associated with CVD health outcomes, 
independent of CRF, it is possible that this is true for AS too (Åberg et al., 2015; 
Silventoinen et al., 2009; Timpka et al., 2014). When trying to examine the independent 
effects of CRF, muscular strength needs to be controlled for.  
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Muscular strength 
 Previous research provides contradicting results about the effects of resistance 
training on AS. Most often, resistance training results in no change in AS, however both 
increases and decreases in AS have also been reported (Ashor et al., 2014; Miyachi, 
2013). This inconsistency is most likely due to the specific type of resistance training. 
Resistance training that results in increased AS are seen in high-intensity training 
programs that involve supersets and extremely high volume. In contrast, progressive 
training programs often results in no change in AS (Braith & Stewart, 2006). Similar to 
CRF, there are many factors that influence MS, but MS is primarily used as an objective 
surrogate for resistance training, and examining the relationship between MS and AS 
could provide some clarity.  
 The relationship between MS and AS is not heavily studied, and the majority of 
research has been conducted in young adults. Strength, measured by one repetition 
maximum, was inversely associated with PWV in young men (r=-0.22, p=0.05), and was 
independent of CRF (r=-0.189, p<0.05). When comparing low and high AS, young men 
with high AS had significantly lower MS (p<0.05) (Fahs, Heffernan, Ranadive, Jae, & 
Fernhall, 2010). Also in young men, MS was a stronger determinant of AS than 
bodyweight. (Roberts et al., 2015). MS appears to have a strong inverse relationship with 
AS, in young men. 
 In a study that included adults 18-75 years old, both relative (total strength/lean 
body mass) (r=-0.48, p<0.001) and absolute strength (r=-0.23, p=0.03) were inversely 
associated with AS. The inverse relationship between MS was attenuated, but remained 
significant after adjustment for age, sex, percent body fat, or mean arterial pressure for 
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relative strength, and only sex and mean arterial pressure for absolute strength. Since 
relative strength is more representative of muscle function, the authors suggested that 
vascular function is more related to muscle function than muscle mass (Fahs et al., 2018). 
This suggests that muscle function is inversely related to AS across a wide age range of 
adults. 
 The few studies in older adults provide mixed results. In a prospective study, grip 
strength at baseline was not associated with PWV at two years follow-up. However, there 
was no significant change in PWV over the two years, which contradicts the 1% increase 
in PWV per year (and even more after the age of 55) established by previous studies 
(Alecu et al., 2006; van Dijk et al., 2015). In contrast, leg strength was related to higher 
artery elasticity in older women (r=0.32, p<0.05) (Hunter et al., 2014).  
 Recent research suggests that there is a relationship between vascular aging and 
age-related muscle loss (sarcopenia) (Abbatecola et al., 2012; Ochi et al., 2010; Sampaio 
et al., 2014; Yoo et al., 2018). In a prospective cohort of older adults, arterial stiffness 
(PWV) was correlated with lower leg mass in all men and white women (β = -0.2196, p = 
0.0002 and β = -0.1608, p = 0.0027, respectively), and arm mass in men (β = -0.0985, p = 
0.0011) (Abbatecola et al., 2012). It is proposed that arterial stiffening and sarcopenia 
may share similar pathways (like endothelial dysfunction, oxidative stress, inflammation, 
and insulin resistance) (Abbatecola et al., 2012; Beyer et al., 2018; Ochi et al., 2010). 
Since grip strength is a tool commonly used to assess muscle strength in diagnosing 
sarcopenia, it could potentially reveal associations between arterial stiffness and muscular 
strength (Cruz-Jentoft et al., 2010; Sousa-Santos & Amaral, 2017). Additionally, higher 
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grip strength was associated with less cardiac remodeling and hypertrophy, providing a 
potential mechanism linking higher grip strength to lower CVD risk (Beyer et al., 2018). 
Since maintaining MS has been shown to be an important aspect of healthy aging, 
more research is needed to clarify the relationship between MS and AS, specifically in 
older adults (Nelson, Rejeski, Blair, Duncan, & Judge, 2007). 
 
Conclusion 
As an emerging CVD risk factor, AS is largely determined by age and is a strong 
indicator of cardiovascular health, making it a relevant assessment of cardiovascular 
health in older adults (Avolio, 2013; Ben-Shlomo et al., 2014; Fagard et al., 2007; 
Mitchell et al., 2010b; Niiranen et al., 2016; Van Bortel et al., 2012; Charalambos 
Vlachopoulos et al., 2010). Many studies have investigated the associations between CRF 
and AS in older adults, revealing a consistent inverse relationship, which gets stronger 
with age (Y. Gando et al., 2010; Tanaka et al., 1998; Vaitkevicius, Fleg, Engel, 
O’Connor, et al., 1993). Reinforcing the need to maintain and improve CRF for 
cardiovascular health in older adults (Tanaka et al., 1998; Vaitkevicius, Fleg, Engel, 
O’Connor, et al., 1993). 
In contrast, very few studies have examined the association between MS and AS 
in any population (Fahs et al., 2010, 2018; Hunter et al., 2014; Roberts et al., 2015). 
While there seems to be a beneficial association between higher MS and lower AS, 
further research is needed to clarify the relationship, specifically in older adults (Fahs et 
al., 2010, 2018; Hunter et al., 2014; Roberts et al., 2015).  
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While not often done, it is important to account for MS when examining the 
relationship of CRF with AS, and vice versa, to determine the independent associations 
(Artero et al., 2012). Since studies show that CRF and MS are independently associated 
with CVD outcomes, there is possibility to suggest they may also be independently 
associated with AS. Examining the joint associations between CRF and MS could 
provide novel information, and a possible additive benefits of both, that influences how 
physical activity and exercise are utilized to reduce arterial stiffening, due to age, CVD, 
or other chronic diseases.  
Finally, examining the associations of CRF and MS, with AS using simple and 
safe assessments for CRF and MS could provide clinically relevant information. The 400-
meter walk and grip strength could be easily and safely assessed, and potentially provide 
insight on cardiovascular risk factors such as AS.   
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CHAPTER 3. METHODOLOGY 
 
Participants 
The Physical Activity and Aging Study (PAAS) cohort is composed of about 600 
older adults in the Ames, Iowa area. The participants were recruited beginning in October 
2015 and continue to be added to the study since it is an open cohort. The only inclusion 
criteria is that adults are 65 years of age or older, with no plans to permanently move out 
of Iowa. Participants were excluded from this analysis if they had diabetes or a CVD 
event within the past two years, to minimize strong potential confounding effects, or 
missing values for CRF (400-meter walk time), MS (grip strength), or (AS) PWV. 
PAAS is a slightly modified continuation of the previous Physical Activity and 
Sarcopenia Study (2015-2016). In fall of 2017, all Physical Activity and Sarcopenia 
Study participants were invited to continue participation in PAAS, which about 60% did. 
Additionally, 350 new participants were recruited to the study.  
The Iowa State University Institutional Review Board approved this study 
(Appendix A). All participants signed an Informed Consent document before beginning 
participation. 
 
Data Collection Procedures 
Participants are invited as often as one time per year for a comprehensive medical 
assessment. This includes two assessments, over the course of one week. At the first visit, 
participants complete the medical history questionnaire and fitness, function, and strength 
assessments. A week later, participants complete fasted assessments including body 
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composition, blood pressure and arterial stiffness, and a blood draw. Between visits 
participants are given physical activity monitors to record their typical physical activity 
levels. Prior to participation, procedures are fully explained and participants provide 
informed consent. 
 
Arterial stiffness 
Carotid-femoral PWV is the gold standard, and most frequently used index, for 
assessing AS, and was the primary outcome of interest (Alvim et al., 2017; Van Bortel et 
al., 2012). Carotid-femoral PWV is measured using the 
Sphygmacor XCEL (AtCor Medical, Itasca, IL, USA). PWV 
measured by the Sphygmacor XCEL device is both accurate 
(rated “excellent,” mean difference <0.05 m/s) and valid 
according to the ARTERY Society guidelines (Butlin & 
Qasem, 2017; Hwang et al., 2014). Additionally, XCEL PWV 
measurements demonstrated repeatability within sessions (p = 
0.66) and between sessions (p = 0.96) (Hwang et al., 2014).  
This assessment was performed while participants were fasted (no food or 
caffeine for 12 hours prior to assessment) and after ten minutes of resting quietly. 
Additionally, this assessment was performed in the same room (centrally-controlled 
temperature) during the same morning time frame for all participants. Participants were 
in a supine position (lying on their back) with a femoral pressure cuff placed on their 
upper left thigh. The femoral cuff obtains a volumetric displacement waveform while 
applanation tonometry simultaneously acquires the carotid pulse, allowing the device to 
Figure 7. PWV using the 
Sphygmacor XCEL device 
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estimate the transit time of pressure waveforms (Butlin & Qasem, 2017). Prior to the 
PWV assessment, linear measurements from the suprasternal notch to both the site of 
carotid applanation tonometery and the top of the femoral cuff were obtained. This allows 
the device to estimate the vascular path length (Butlin & Qasem, 2017). The Sphygmacor 
XCEL device uses the transit time and vascular path length to estimate PWV. At least 
two PWV measurements were performed, and if the first two differed by more than 0.5 
m/s, a third measurement was taken (Van Bortel et al., 2012). 
Another potential variable of interest acquired from the Sphygmacor XCEL 
device was Augmentation Index. Augmentation Index assesses the shape of the reflected 
pulse wave. This provides insight into the stiffness of both elastic and muscular arteries, 
in contrast to carotid-femoral PWV which only indicates the stiffness of large (elastic) 
arteries (Lima-Junior et al., 2018).  
 
Cardiorespiratory fitness 
In older adults, the 400-meter walking test is associated with VO2max from 
maximal treadmill test (r = -0.79), submaximal treadmill test (r = -0.66, p < 0.001), and 
estimation with prediction equation (r = -0.60, p < 0.0001) (Pettee Gabriel et al., 2010; 
Simonsick et al., 2006). Walking time was also independently associated with both self-
reported physical activity (p = 0.0001) and accelerometer-assessed physical activity 
(p<0.05) (Anne B Newman et al., 2003). The 400-meter walking test demonstrated 
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excellent reproducibility, when tests were repeated a week apart (ICC = 0.95 [95% CI 
0.92, 0.97]) (Pettee Gabriel et al., 2010). 
CRF was assessed by the time (seconds) required to walk 10 laps as fast as 
possible, on a 20-meter long course (400-meters). Cones marked the ends of the course 
and participants were instructed to walk as quickly as possible, without running (A. B. 
Newman, Haggerty, Kritchevsky, Nevitt, & Simonsick, 2003; Simonsick et al., 2006). 
Participants were allowed to rest up to 60 seconds if they remained standing. The 
maximum time allowed was 15 minutes.  
 
Figure 8. 400-meter walk course diagram 
 
Muscular strength 
Grip strength is often used as an indicator of overall muscular strength (Avlund, 
Schroll, Davidsen, Løvborg, & Rantanen, 1994; Ling et al., 2010; Rantanen et al., 1998). 
In older adults, handgrip force was 
correlated to elbow flexion (men: r 
= 0.638, p<0.001; women: r = 
0.672, p<0.001), knee extension 
(men: r = 0.524, p<0.001; women: 
r = 0.514, p<0.001), trunk 
extension (men: r = 0.515, Figure 9. Grip strength measurement using a digital dynamometer. 
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p<0.001; women: r = 0.541, p<0.001), and trunk flexion (men: r = 0.427, p<0.001; 
women: r = 0.524, p<0.001) forces (Avlund et al., 1994). Additionally, Fragala et al. 
(knee extension and flexion) and Alonso et al. (leg extension) both demonstrated that 
handgrip strength was associated with leg strength in older adults, supporting the use of 
grip strength as a proxy for overall muscular strength (Alonso et al., 2018; Fragala et al., 
2016). 
The Jamar dynamometer is the “gold standard” device for the measurement of 
grip strength and is a valid and reliable measure of handgrip strength (Mathiowetz, 2002). 
The dynamometer was correlated with known weights (r = 0.9998) and demonstrated 
both within-instrument (r = 0.82, p <0.001), and inter-instrument (ICC ranging 0.90-
0.97), reliability (Hamilton, McDonald, & Chenier, 1992; Mathiowetz, 2002). 
Muscular strength was assessed by grip strength, using a digital dynamometer 
(Jamar Plus+12-064, Lafayette Instrument, Lafayette, IN, USA). The dynamometer was 
adjusted so that the middle two fingers formed a 90 degree angle when gripping the 
device. During the assessment, participants sat with their wrist in a neutral position and 
elbow at a right angle. They were instructed to maximally grip the dynamometer, holding 
the maximum contraction for two seconds. Alternating sides with one minute of rest 
between each measurement, three trials were completed on each hand.  
 
Covariates 
Height, weight, mean arterial pressure and the blood lipid panel were also 
completed while fasted (12-hours). Height (cm) was measured with a standard 
stadiometer and weight (kg) using a scale. Body mass index (BMI) was calculated using 
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the weight (kg) divided by height (meters) squared. PWV varies depending on the 
instantaneous distending pressure, which is best represented by mean arterial pressure 
(MAP) (Quinn et al., 2012). MAP was assessed using the Sphygmacor XCEL automated 
device (AtCor Medical, Itasca, IL, USA). The participant laid supine with a brachial cuff 
placed on the left arm. The device automatically took three readings. MAP from the 
Sphygmacor XCEL device is used because analysis of PWV measurements should take 
into account MAP at the time of the measurement (Quinn et al., 2012). Blood chemistry 
analysis provides a lipid profile (total cholesterol, low-and high-density lipoprotein 
cholesterol, and triglycerides) and blood glucose. A certified phlebotomist drew one tube 
(about 5 mL) of blood from a superficial arm vein.  
Medical history and/or current medications (diabetes, stroke, myocardial 
infarction, congestive heart failure, and hypertension) and lifestyle factors (smoking 
status and heavy alcohol consumption) was self-reported in a questionnaire.  
Physical activity was assessed using an accelerometer-based pedometer (Omron, 
Model HJ-321, IL, USA). The pedometer was worn at the waist for 7 days. Based on 
published cut-points for older adults, participants were classified as not meeting physical 
activity guidelines(<7500 steps/day) or meeting physical activity guidelines (7500 
steps/day) (Tudor-Locke et al., 2011). 
 
Data Analysis Procedures 
 Participants were split into sex-specific tertiles for CRF and MS. Further, CRF 
and MS were dichotomized into either weak (e.g., lower one-third) or strong (e.g., upper 
two-thirds) and unfit (e.g., lower one-third) or fit (e.g., upper two-thirds) for a joint 
analysis of CRF and MS with high AS. These groups were based on the associations of 
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each CRF and MS with high AS, as well as following earlier studies (Åberg et al., 2015; 
Artero et al., 2011; Jae et al., 2010; McAuley et al., 2009; Sui, Laditka, et al., 2007). 
Since our population is all older adults (≥ 65), living independently, and relatively fitter 
and healthier than the general older adult population (as they all volunteered for the 
study), comparing these quantitatively different groups may help reveal the general 
associations between CRF and MS with AS.  
High AS was defined as a PWV of 10 m/s or greater, as it has been established as 
a threshold for increased cardiovascular risk (Van Bortel et al., 2012). Sensitivity 
analyses using different categories of CRF and MS (e.g., quartiles, quintiles) were also 
explored.  
Statistical Analysis Procedures 
Descriptive statistics 
 Descriptive statistics were calculated for each variable and compared between 
men and women using χ2 (categorical) and ANOVA (continuous). 
To meet the assumptions of linear regression, PWV was log-transformed before 
performing statistical analysis. Before the transformation, the Breusch-Pagan test 
indicated heteroscedasticity (p = 0.048 and p = 0.042 for CRF and MS, respectively.) The 
assumption was no longer violated after the log-transformation of PWV (p = 0.726 and p 
= 0.543 for CRF and MS, respectively.) Mutlicollinearity was assessed with variance 
inflation factor (VIF); VIF > 3 was identified as collinear. None of the predictor variables 
were identified as collinear in any of the models, for CRF or MS with PWV, so all were 
included in analysis. 
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Aim 1 
To test the hypothesis that higher CRF is associated with lower AS, independent of MS, 
we used two statistical methods: 1) multivariable linear regression analysis to determine 
unstandardized and standardized betas (βs), with CRF (400-meter walk) as the 
independent variable and both PWV (primary) and AIx (secondary) as dependent 
variables, with adjustment for age, sex, mean arterial pressure (MAP), BMI, and MS. 
Then, it was repeated with further adjustment for lifestyle factors (e.g., inactivity, 
smoking, and heavy alcohol consumption [>14 drinks per week for male, >7 for female]) 
and comorbidities (e.g., CVD, HTN, obesity, dyslipidemia). 2) multivariable logistic 
regression was used to calculate odds ratios (ORs) and 95% confidence intervals (95% 
CIs) of having high AS across sex-specific tertiles of CRF, adjusting for age, mean 
arterial pressure, BMI, physical activity, smoking, heavy alcohol consumption, and MS. 
 
Aim 2 
To test the hypothesis that higher MS is associated with lower AS, independent of CRF, 
we used two statistical methods: 1) multivariable linear regression analysis to determine 
unstandardized and standardized betas (βs), with MS (grip strength) as the independent 
variable and both PWV (primary) and AIx (secondary) as dependent variables, with 
adjustment for age, sex, MAP, BMI, and CRF. Then, it was repeated with further 
adjustment for lifestyle factors and comorbidities. 2) multivariable logistic regression was 
used to calculate odds ratios (ORs) and 95% confidence intervals (95% CIs) of having 
high AS across sex-specific tertiles of MS, adjusting for age, mean arterial pressure, 
BMI, physical activity, smoking, heavy alcohol consumption, and CRF. 
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Aim 3 
To test the hypothesis that the combined association of CRF and MS are stronger than 
either CRF or MS alone, multivariable logistic regression was used to calculate ORs and 
95% CI of having high AS across combined categories of CRF and MS (Åberg et al., 
2015; Artero et al., 2011). CRF and MS were dichotomized, to keep sufficient numbers in 
each category, to perform a joint analysis. Four categories were created (e.g., unfit/weak, 
unfit/strong, fit/weak, and fit/strong), based on the associations between CRF and MS 
with AS from Aims 1 and 2.  
The analysis was repeated stratifying by sex, physical activity, hypertension, and 
BMI categories. 
 
Exploratory analysis  
In an exploratory analysis, the same analyses were repeated in a subset of 
participants who also participated in the Physical Activity and Sarcopenia Study (PAAS) 
in 2015-2016. These analyses used CRF assessed by treadmill submaximal test and 400-
meter walk, MS by one-repetition max assessments and grip strength, and AS measured 
at 2-3 years follow-up. 
 Statistical analysis was performed using SAS software (SAS Institute, Cary, NC), 
all p < 0.05 will be considered significant. 
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CHAPTER 4. RESULTS 
 
Since the addition of the arterial stiffness assessment from October 2017 to 
December 2018, 497 individuals participated in the Physical Activity and Aging Study. 
Participants were excluded from analysis if they had diabetes (n=52), myocardial 
infarction, stroke, or congestive heart failure within the past two years (n=15), or missing 
data for any of the main exposures or outcome (CRF, MS, or PWV) (n=3). Therefore, the 
analysis included 427 older adults aged at least 65 years old. There was no significant 
interaction between sex and CRF or MS, so the main analyses (linear and logistic 
regressions) were performed on men and women combined (p > 0.05).  
Sex-specific tertiles were created for both CRF and MS, and mean values and cut-
points are provided in Table 1. Characteristics of the study sample are reported in Table 
2, according to CRF and MS tertiles. Participants in the upper CRF group were more 
likely to be younger, stronger, more physically active (steps/day), with lower body 
weight, BMI, systolic blood pressure, and PWV. Participants in the upper MS group were 
also more likely to be younger and fitter with lower body weight and PWV. Besides 
physical activity level between CRF groups, there were no significant differences in 
lifestyle factors between levels of CRF or MS (Table 2).  
Table 1. Cut-points for Sex-specific Cardiorespiratory Fitness and Muscular 
Strength Tertiles. 
  Cardiorespiratory  
Fitness (s) 
Muscular Strength (kg) 
  Lower Middle Upper Lower Middle Upper 
Women 
Cut-points > 286 286 - 258 < 258 < 23.0 23.0 - 29.0 > 29.0 
Mean 324 272 239 19.5 26.3 35.2 
Men 
Cut-points > 268 268 - 241 < 241 < 38.1 38.1 – 46.1 > 46.1 
Mean 305 254 220 32.9 42.0 53.6 
Cardiorespiratory fitness: time (s) to complete 400-meter walking test. 
Muscular strength: overall grip strength (kg); maximum value (out of 3 trials) from each hand, averaged. 
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Table 2. Characteristics of Study Participants by Cardiorespiratory Fitness and Muscular 
Strength. 
  Tertile of Cardiorespiratory 
Fitness 
 Tertile of Muscular  
Strength 
 
Characteristic Total Lower Middle Upper 
P-
value 
Lower Middle Upper 
P-
value 
n 427 142 138 147  141 143 143  
Age, y 72 (6) 75 (6) 71 (5) 70 (5) <.001 74 (7) 72 (5) 71 (5) <.001 
Weight, kg 
76.8 
(15.8) 
79.9 
(17.4) 
77.5 
(15.6) 
73.0 
(13.5) 
0.001 
75.5 
(16.0) 
75.1 
(15.1) 
79.6 
(16.2) 
0.030 
Body mass index, kg/m2 
27.4 
(4.5) 
28.9 
(5.0) 
27.9 
(4.2) 
25.6 
(3.6) 
<.001 
27.8 
(4.5) 
27.0 
(4.7) 
27.4 
(4.4) 
0.261 
Normal weight, n (%) 
132 
(31) 
34 (24) 37 (26) 62 (42)  38 (27) 51 (36) 42 (29)  
Overweight, n (%) 
182 
(43) 
55 (39) 57 (41) 70 (48)  59 (42) 58 (41) 67 (47)  
Obese, n (%) 
113 
(26) 
51 (37) 46 (33) 15 (10)  44 (31) 34 (4) 34 (24)  
Mean arterial pressure, mmHg 92 (10) 94 (10) 93 (9) 91 (10) 0.062 93 (10) 92 (9) 92 (10) 0.756 
Systolic BP, mmHg 
131 
(14) 
135 
(15) 
131 
(14) 
128 
(14) 
<.001 
134 
(15) 
131 
(13) 
129 
(15) 
0.057 
Diastolic BP, mmHg 75 (8) 76 (9) 76 (8) 75 (8) 0.639 75 (8) 75 (8) 76 (9) 0.959 
Hypertensivea, n (%) 
182 
(43) 
71 (51) 65 (46) 47 (32) 0.004 66 (47) 57 (40) 61 (43) 0.251 
Pulse Wave Velocityb, m/s 
8.5 
(1.6) 
9.2 
(1.8) 
8.2 
(1.5) 
8.1 
(1.4) 
<.001 
8.9 
(1.8) 
8.5 
(1.6) 
8.2 
(1.3) 
0.002 
Augmentation Indexc, % 32 (11) 32 (12) 32 (11) 31 (9) 0.347 33 (13) 32 (9) 30 (10) 0.138 
Steps per dayc 
5800 
(3054) 
4643 
(2323) 
5813 
(3139) 
6905 
(3201) 
<.001 
5569 
(2725) 
6213 
(3562) 
5667 
(3039) 
0.128 
Not meeting physical activity 
guidelinesd, n (%) 
319 
(75) 
123 
(88) 
106 
(76) 
90 (61) <.001 
113 
(80) 
100 
(70) 
109 
(76) 
0.051 
Current smoker, n (%) 4 (1) 1 (1) 2 (1) 1 (1) 0.749 1 (1) 2 (1) 1 (1) 0.781 
Heavy Alcohol Intakee, n (%) 30 (7) 7 (5) 12 (9) 11 (7) 0.451 8 (6) 9 (6) 12 (8) 0.669 
Cardiovascular Diseasef, n (%) 23 (5) 13 (9) 7 (5) 4 (3) 0.096 13 (9) 7 (5) 4 (3) 0.098 
Low-density lipoprotein 
cholesterol, mg/dl 
106 
(30) 
102 
(31) 
108 
(32) 
109 
(26) 
0.101 
104 
(31) 
105 
(28) 
109 
(30) 
0.395 
Hypercholesterolemiag, n (%) 
225 
(53) 
77 (55) 78 (56) 69 (47) 0.218 81 (57) 68 (48) 74 (52) 0.156 
400-meter walk time, s 
270 
(44) 
316 
(40) 
264 
(12) 
230 
(20) 
<.001 
290 
(47) 
265 
(38) 
255 
(39) 
<.001 
Overall grip strengthh, kg 
34.0 
(11.7) 
30.1 
(10.4) 
34.5  
(11.5) 
37.4 
(11.9) 
<.001 
25.3 
(7.7) 
33.2 
(8.1) 
43.3 
(11.1) 
<.001 
Unless otherwise indicated, values are presented as mean (SD) 
aself-reported: diagnosed hypertension and/or taking blood pressure medication; bcarotid-femoral pulse wave velocity; cpulse 
wave analysis; d < 7500 steps/day; e > 14 drinks/week for men, >7 drinks/week for women; f history of myocardial infarction 
and/or stroke; glow-density lipoprotein cholesterol ≥ 190 mg/dl; hmaximum value (out of 3 trials) from each hand, averaged. BP= 
blood pressure 
 
Tables 3 shows the independent associations of CRF with PWV. Multivariate 
linear regression analysis indicated there was an inverse relationship between CRF and 
arterial stiffness (as time to complete 400-meter walk increased, suggesting lower fitness, 
PWV increased), when controlling for age and sex (model R2 = 0.180, p < 0.001). The 
relationship was no longer significant after further adjustment for mean arterial pressure 
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(MAP) or lifestyle factors (body mass index, inactivity, current smoking status, and 
heavy alcohol intake), and the CRF parameter estimate was cut in half (model 1 β = 3.45; 
model 2 β = 1.74) (Table 3). However, further adjustment for MS had little effect on the 
magnitude of the CRF parameter estimate (model 2 β = 1.74; model 3 β = 1.43) (Table 
3).  
Table 3. Multivariable Linear Regression of Cardiorespiratory Fitness with Pulse Wave Velocity. 
 Model 1  Model 2 Model 3 
 
B 
(SE) 
β 
p-
value 
B 
(SE) 
β 
p-
value 
B 
(SE) 
β 
p-
value 
Cardiorespiratory 
fitnessa, s 
0.08 
(0.02) 
3.45 <.001 
0.04 
(0.02) 
1.74 0.057 
0.03 
(0.02) 
1.43 0.139 
Age, y 
0.84 
(0.15) 
4.92 <.001 
0.91 
(0.14) 
5.35 <.001 
0.90 
(0.14) 
5.27 <.001 
Sex 
10.70 
(1.70) 
5.18 <.001 
8.29 
(1.60) 
4.04 <.001 
9.61 
(2.07) 
4.67 <.001 
Mean arterial pressureb, 
mmHg 
─ ─ ─ 
0.77 
(0.08) 
7.84 <.001 
0.77 
(0.08) 
7.83 <.001 
Body mass index, kg/m2 ─ ─ ─ 
0.17 
(0.19) 
0.78 0.353 
0.19 
(0.19) 
0.87 0.301 
Not meeting PA 
guidelinesc 
─ ─ ─ 
1.64 
(1.76) 
0.71 0.351 
1.77 
(1.77) 
0.76 0.317 
Current smoker ─ ─ ─ 
5.13 
(7.79) 
0.45 0.506 
5.14 
(7.79) 
0.45 0.505 
Heavy alcohol intaked ─ ─ ─ 
7.42 
(2.89) 
2.40 0.012 
7.47 
(2.89) 
2.42 0.012 
Muscular strengthe, kg ─ ─ ─ ─ ─ ─ 
-0.09 
(0.09) 
-0.97 0.346 
Adj-R2 0.1801 0.3628 0.3627 
p-value <0.001 <0.001 <0.001 
PA = physical activity 
a time (s) to complete 400-meter walking test; bpulse wave analysis; c < 7500 steps/day; d > 14 drinks/week for men, >7 
drinks/week for women; e overall grip strength (kg); maximum value (out of 3 trials) from each hand, averaged 
Pulse wave velocity was log-transformed, therefore PWV outcomes are expressed as the percentage difference (standard error). 
Regression coefficients were back-transformed using (100*(exp(β)-1)) to calculate the percentage difference and standard error 
of PWV for each variable. How to interpret: for every 1-year increase in age, the mean pulse wave velocity increases by 0.84%. 
β = standardized regression coefficients 
Model 1: adjusted for age and sex 
Model 2: model 1 further adjusted for mean arterial pressure, body mass index, inactivity, current smoking status, and heavy 
alcohol intake 
Model 3: model 2 further adjusted for muscular strength 
 
Logistic regression was used to investigate arterial stiffness across levels of CRF 
(Table 4). The middle and upper CRF tertiles were associated with reduced odds of 
having high PWV. Compared to lower CRF, the OR (95% CI) for older adults in the 
middle and upper CRF categories were 0.44 (0.23-0.85) and 0.48 (0.25-0.94) for having 
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high PWV, respectively, after controlling for age and sex (Table 4). After further 
adjustment for mean arterial pressure and lifestyle factors, OR (95% CI) of middle CRF 
was 0.46 (0.22-0.95) of having high PWV, and the reduced odds in upper CRF was no 
longer significant (OR, 0.54 [95% CI 0.25-1.18]). The reduced odds in middle CRF was 
no longer significant after further adjustment for MS (OR, 0.53 [95% CI 0.25-1.12]) 
(Table 4). Additionally, there was a linear trend when controlling for age, sex, BMI, 
MAP, and lifestyle factors (p for trend = 0.023 and 0.088 for models 1 and 2, 
respectively). However, this trend did not remain after further adjustment for MS (p for 
trend = 0.328) (Table 4). 
Table 4. Odds Ratios of High Arterial Stiffness by Cardiorespiratory Fitness Tertiles. 
   Model 1 
OR (95% CI) 
Model 2 
OR (95% CI) 
Model 3 
OR (95% CI)  n Case 
Lower CRF  142 40 1.00 (reference) 1.00 (reference) 1.00 (reference) 
Middle CRF  138 16 0.44 (0.23-0.85) 0.46 (0.22-0.95) 0.53 (0.25-1.12) 
Upper CRF 147 17 0.48 (0.25-0.94) 0.54 (0.25-1.18) 0.71 (0.31-1.62) 
p-trend 0.023 0.088 0.328 
Odds ratios (95% confidence intervals) of high arterial stiffness by cardiorespiratory fitness tertiles. Case: High 
arterial stiffness = pulse wave velocity > 10 m/s 
Cardiorespiratory fitness, CRF: time (s) to complete 400-meter walking test 
Model 1: adjusted for age and sex 
Model 2: model 1 further adjusted for mean arterial pressure, body mass index, not meeting PA guidelines, current 
smoking status, and heavy alcohol intake 
Model 3: model 2 further adjusted for muscular strength (overall grip strength (kg); maximum value (out of 3 
trials) from each hand, averaged) 
Table 5 shows the independent associations of MS with PWV. While multivariate 
linear regression revealed that MS was not a significant predictor of PWV in any of the 
models, there is an inverse relationship between MS and PWV. Unlike for CRF, the 
parameter estimate for MS was only slightly reduced when further adjusting for MAP, 
BMI, and lifestyle factors (model 1 β = -1.81; model 2 β = -1.48) (Table 5). Further 
adjustment for CRF also had a small effect on the MS parameter estimate (model 2 β = -
1.48; model 3 β = -0.97) (Table 5).  
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Logistic regression was also used to investigate arterial stiffness across levels of 
MS (Table 6). The middle and upper MS tertiles were associated with reduced odds of 
having high PWV; however, only the upper MS was statistically significant in all three 
models. Compared to lower MS, OR (95% CI) for upper MS was 0.40 (0.20-0.80), after 
adjustment for age and sex, and 0.32 (0.15-0.70) after further adjustment for mean 
arterial pressure and lifestyle factors (Table 6). Additionally, this association remained 
statistically significant after further adjustment for CRF (OR, 0.34 [95% CI 0.15-0.77]) 
indicating an independent association of MS with reduced odds of having high PWV 
Table 5. Multivariable Linear Regression of Muscular Strength with Pulse Wave Velocity. 
 Model 1  Model 2 Model 3 
 
B 
(SE) 
β 
p-
value 
B 
(SE) 
β 
p-
value 
B 
(SE) 
β 
p-
value 
Muscular strengtha, kg 
-0.16 
(0.10) 
-1.81 0.103 -0.13 
(0.09) 
-1.48 0.128 -0.09 
(0.09) 
-0.97 0.346 
Age, y 
0.99 
(0.15) 
5.81 <.001 0.97 
(0.13) 
5.70 <.001 0.90 
(0.14) 
5.27 <.001 
Sex 
11.98 
(2.31) 
5.79 <.001 9.51 
(2.07) 
4.62 <.001 9.61 
(2.07) 
4.67 <.001 
Mean arterial pressureb, 
mmHg 
─ ─ ─ 0.79 
(0.08) 
7.94 <.001 0.77 
(0.08) 
7.83 <.001 
Body mass index, kg/m2 
─ ─ ─ 0.32 
(0.17) 
1.43 0.059 0.19 
(0.19) 
0.87 0.301 
Not meeting PA guidelinesc 
─ ─ ─ 2.10 
(1.76) 
0.91 0.234 1.77 
(1.77) 
0.76 0.317 
Current smoker 
─ ─ ─ 4.70 
(7.79) 
0.42 0.541 5.14 
(7.79) 
0.45 0.505 
Heavy alcohol intaked 
─ ─ ─ 7.34 
(2.89) 
2.38 0.013 7.47 
(2.89) 
2.42 0.012 
Cardiorespiratory fitnesse, s 
─ ─ ─ ─ ─ ─ 0.03 
(0.02) 
1.43 0.139 
Adj-R2 0.1576 0.3728 0.3627 
p-value <0.001 <0.001 <0.001 
PA = physical activity 
a overall grip strength (kg); maximum value (out of 3 trials) from each hand, averaged; bpulse wave analysis; c < 7500 steps/day; d 
> 14 drinks/week for men, >7 drinks/week for women; e time (s) to complete 400-meter walking test 
Pulse wave velocity was log-transformed, therefore PWV outcomes are expressed as the percentage difference (standard error). 
Regression coefficients were back-transformed using (100*(exp(β)-1)) to calculate the percentage difference and standard error 
of PWV for each variable. How to interpret: for every 1-year increase in age, the mean pulse wave velocity increases by 0.84%. 
β = standardized regression coefficients 
Model 1: adjusted for age and sex 
Model 2: model 1 further adjusted for mean arterial pressure, body mass index, inactivity, current smoking status, and heavy 
alcohol intake 
Model 3: model 2 further adjusted for muscular strength 
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(Table 6). Additionally, there was a linear trend in all models (p for trend = 0.004 - 
0.008) (Table 6). 
Table 6. Odds Ratios of High Arterial Stiffness by Muscular Strength Tertiles. 
   Model 1 
OR (95% CI) 
Model 2 
OR (95% CI) 
Model 3 
OR (95% CI)  n Case 
Lower MS  141 37 1.00 (reference) 1.00 (reference) 1.00 (reference) 
Middle MS  143 22 0.62 (0.34-1.15) 0.58 (0.30-1.15) 0.60 (0.30-1.19) 
Upper MS 143 14 0.40 (0.20-0.80) 0.32 (0.15-0.70) 0.34 (0.15-0.77) 
p-trend 0.008 0.004 0.008 
Odds ratios (95% confidence intervals) of high arterial stiffness by muscular strength tertiles 
Case: High arterial stiffness = pulse wave velocity > 10 m/s 
Muscular strength, MS: overall grip strength (kg)  
Model 1: adjusted for age and sex 
Model 2: model 1 further adjusted for mean arterial pressure, body mass index, inactivity, current smoking status, and heavy 
alcohol intake 
Model 3: model 2 further adjusted for cardiorespiratory fitness (time (s) to complete 400-meter walking test) 
 
Table 7 shows odds of having high PWV across CRF and MS tertiles, stratified 
by sex, physical activity, hypertension, and BMI classification that are considered as 
other possible risk factors of AS. Overall, the stratified analysis revealed consistent trends 
across all strata. Although the associations were only significant in older adults that meet 
the physical activity guidelines (≥ 7500 steps/day) for CRF and men, not meeting the 
physical activity guidelines, and overweight/obese for MS. Not significant results are 
partly because of lower numbers of cases (< 10 cases in many groups) in these stratified 
analyses with more categories in both CRF and MS. Additionally, the stratified analysis 
confirmed no interactions (all interaction p-values > 0.05) (Table 7). 
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Table 7. Odds Ratios of High Arterial Stiffness by Cardiorespiratory Fitness and Muscular 
Strength Tertiles, Stratified by Sex, Physical Activity, Hypertension, and Body Mass Index.  
 Cardiorespiratory Muscular Strength 
 n Case OR (95% CI) Interaction 
p-value 
n Case OR (95% CI) Interaction 
p-value 
Overall         
Lower 142 40 1.00 (reference)  141 37 1.00 (reference)  
Middle 138 16 0.53 (0.25-1.12)  143 22 0.60 (0.30-1.19)  
Upper 147 17 0.71 (0.31-1.62)  143 14 0.34 (0.15-0.77)  
 p-trend 0.328  p-trend 0.008  
Women   
 
   
 
 
Lower 79 18 1.00 (reference)  79 15 1.00 (reference)  
Middle 79 6 0.47 (0.15-1.51)  80 10 0.68 (0.25-1.87)  
Upper 81 8 0.99 (0.28-3.50)  80 7 0.51 (0.16-1.60)  
 p-trend 0.893  p-trend 0.239  
Men    0.430    0.225 
Lower 63 22 1.00 (reference)  62 22 1.00 (reference)  
Middle 59 10 0.63 (0.22-1.77)  63 12 0.42 (0.15-1.14)  
Upper 66 9 0.56 (0.18-1.74)  63 7 0.19 (0.05-0.64)  
 p-trend 0.290  p-trend 0.006  
Meeting PA guidelinesa 
 
    
 
Lower 17 7 1.00 (reference)  28 7 1.00 (reference)  
Middle 34 2 0.03 (0.00-0.30)  46 5 0.41 (0.08-2.11)  
Upper 57 4 0.15 (0.02-0.98)  34 1 0.10 (0.01-1.19)  
 p-trend 0.062  p-trend 0.054  
Not meeting PA guidelinesa  0.101    0.319 
Lower 125 33 1.00 (reference)  119 30 1.00 (ref)  
Middle 104 14 0.86 (0.38-1.96)  97 17 0.62 (0.29-1.37)  
Upper 90 13 0.89 (0.35-2.28)  109 13 0.38 (0.16-0.93)  
 p-trend 0.773  p-trend 0.032  
Non-hypertensiveb       
Lower 70 16 1.00 (reference) 
 
74 13 1.00 (reference) 
 
Middle 75 6 0.47 (0.15-1.45)  89 11 0.77 (0.28-2.10)  
Upper 100 7 0.52 (0.15-1.76)  82 5 0.46 (0.13-1.60)  
 p-trend 0.263  p-trend 0.224  
Hypertensiveb    0.997    0.465 
Lower 72 24 1.00 (reference)  67 24 1.00 (reference)  
Middle 63 10 0.59 (0.23-1.49)  54 11 0.59 (0.24-1.43)  
Upper 47 10 0.94 (0.32-2.28)  61 9 0.40 (0.16-1.03)  
 p-trend 0.759  p-trend 0.052  
Normal weightc      
 
Lower 33 7 1.00 (reference) 
 
41 6 1.00 (reference)  
Middle 38 3 0.71 (0.13-3.76)  50 8 2.21 (0.47-
10.40) 
 
Upper 63 6 1.85 (0.34-9.89)  43 2 0.35 (0.05-2.61)  
 p-trend 0.474  p-trend 0.315  
Overweight/obesec  0.551    0.755 
Lower 109 33 1.00 (reference)  100 31 1.00 (reference)  
Middle 100 13 0.55 (0.22-1.31)  93 14 0.37 (0.16-0.86)  
Upper 84 11 0.52 (0.20-1.38)  100 12 0.33 (0.13-0.85)  
 p-trend 0.158  p-trend 0.012  
PA = physical activity 
Odds ratios (95% confidence intervals) of high arterial stiffness by cardiorespiratory fitness and muscular strength tertiles.  High 
arterial stiffness is considered a pulse wave velocity > 10 m/s. Cardiorespiratory fitness (CRF) is the time (s) to complete 400-
meter walking test. Muscular strength (MS) is overall grip strength (kg): maximum value (out of 3 trials) from each hand, 
averaged.  
aactive: ≥7500 steps/day, inactive: < 7500 steps/day; b self-reported: diagnosed hypertension and/or taking blood pressure 
medication; cnormal weight: <25 kg/m2, overweight/obese: ≥ 25 kg/m2 
Adjusted for age, sex, mean arterial pressure, body mass index, inactivity, current smoking status, and heavy alcohol intake 
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 Joint analysis was used to investigate the combined effects of CRF and MS on 
PWV.  Compared to the Unfit & Weak group, all other groups were significantly less 
likely to have high PWV. The Unfit & Strong, Fit & Weak, and Fit & Strong groups had 
OR (95% CI) of 0.32 (0.13-0.80), 0.35 (0.13-0.93), and 0.27 (0.12-0.60), respectively, 
indicating reduced odds of high PWV (Figure 10). However, none of these three groups 
were significantly different from each other (data not shown). Although there are some 
variations, similar results were observed in general when stratified by sex, physical 
activity, hypertension, and body mass index (Figure 11). Participant characteristics by 
joint analysis group are shown in the Appendix B. 
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Figure 10. Odds Ratios of High Arterial Stiffness by Combined 
Cardiorespiratory Fitness and Muscular Strength.
Odds ratios (95% confidence intervals) of high arterial stiffness by cardiorespiratory fitness and muscular strength joint 
analysis. High arterial stiffness is considered a pulse wave velocity > 10 m/s. Cardiorespiratory fitness (CRF) is the time 
(s) to complete 400-meter walking test. Muscular strength (MS) is overall grip strength (kg). Participants were divided 
into four groups based on CRF and MS, where Unfit and Weak were the lower 1/3 of CRF and MS, respectively, and Fit 
and Strong were the upper 2/3 of CRF and MS, respectively.
The number of individuals (cases of higher arterial stiffness) in the Unfit & Weak, Unfit & Strong, Fit & Weak, and Fit 
& Strong groups were 75 (27), 67 (13), 66 (10) and, 219 (23), respectively.
The model was adjusted for age, sex, mean arterial pressure, body mass index, inactivity, current smoking status, and 
heavy alcohol intake.
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 Figure 11. Odds Ratios of High Arterial Stiffness by Cardiorespiratory Fitness and Muscular 
Strength Tertiles, Stratified by Sex, Physical Activity, Hypertension, and Body Mass Index.  
Odds ratios (95% confidence intervals) of high arterial stiffness by joint analysis stratified by (A) women or men (B) active 
(≥7500 steps/day) or inactive (<7500 steps/day) (C) not hypertension or hypertensive (self-reported diagnosis and/or taking 
medication) (D) normal weight (<25 kg/m2) or overweight/obese (≥25 kg/m2). High arterial stiffness is considered a pulse 
wave velocity > 10 m/s. Cardiorespiratory fitness (CRF) is the time (s) to complete 400-meter walking test. Muscular 
strength (MS) is overall grip strength (kg). Participants were divided into four groups based on CRF and MS, where Unfit 
and Weak were the lower 1/3 of CRF and MS, respectively, and Fit and Strong were the upper 2/3 of CRF and MS, 
respectively. All data were adjusted for age, sex (except in A), mean arterial pressure, body mass index (except in D), 
inactivity (except in B), current smoking status, and heavy alcohol intake. The number of individuals (cases of higher 
arterial stiffness) in the Unfit & Weak, Unfit & Strong, Fit & Weak, Fit & Strong groups were,40 (13), 39 (5), 39 (2), and 
121 (12) in women; 35 (14), 28 (8) 27 (8), and 98 (11) in men; 8 (4), 9 (3), 20 (3), and 71 (3) in active; 67 (23), 58 (10), 46 
(7), 148 (20) in inactive; 38 (10), 32 (6), 36 (3), 139 (10) in non-hypertensive; 37 (17), 35 (7), 30 (7), and 80 (13) in 
hypertensive; 20 (5), 13 (2), 21 (1), and 80 (8) in normal weight; 55 (22), 54 (11), 45 (9), and 139 (15) in overweight/obese. 
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The analysis was repeated in a subsample of 96 older adults who had CRF 
measured by a treadmill submaximal test, as well as MS measured by chest press and leg 
press one-repetition maximum, and PWV measured 2-3 years later. While linear 
regression revealed consistent inverse relationships between both CRF and MS with 
PWV, no associations (linear or logistic) were significant between any of the CRF or MS 
measures with PWV partly due to the reduced number of participants (data not shown). 
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CHAPTER 5. DISCUSSION 
 
 
Independent Associations of Cardiorespiratory Fitness and Muscular Strength with 
Arterial Stiffness 
 
 
There were 3 major findings of this study: First, CRF assessed by time to complete 
the 400-meter walking test was not a predictor of PWV, independent of MAP, BMI, 
lifestyle factors, or MS based on linear regression analysis. However, the middle CRF 
tertile was associated with reduced odds of having high PWV, independent of MAP, 
BMI, and lifestyle factors, but not independent of MS based on logistic regression. 
Second, MS assessed by overall grip strength was not an independent predictor of PWV 
based on linear regression analysis. However, the upper MS tertile was associated with 
reduced odds of having high PWV, independent of potential covariates including CRF 
based on linear regression. Lastly, any combination of being fit and/or strong was 
associated with significantly reduced odds of having high PWV, compared to the Unfit & 
Weak group. 
CRF is consistently inversely associated with PWV in a variety of populations, 
including older adults (Y. Gando et al., 2010; Hunter et al., 2014; Vaitkevicius, Fleg, 
Engel, O’Connor, et al., 1993). Our results are consistent with this previously established 
relationship; as time to complete the 400-meter walking test increased (suggesting lower 
CRF), PWV increased, although not significant after adjusting potential confounders and 
MS (β = 1.43-3.45, p > 0.05) (Table 3). However, the association is not as strong as 
expected, which is confirmed by a weak correlation (r = 0.19, p < 0.001) between CRF 
and PWV in our cohort of older adults. Similarly weak, yet significant, associations 
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between CRF and PWV were also reported in middle-age men with and without 
metabolic syndrome (r = -0.29, p <0.05 and r = -0.22, p <0.05, respectively) (Jae et al., 
2010). Consistent with our findings, Jae et al. (2010) found an inverse association; as 
CRF increased, PWV decreased. However, because Jae et al. (2010) used peak VO2 to 
assess CRF, their correlation coefficient is negative. Comparably, a significant moderate 
correlation between VO2max and large artery elasticity (r = 0.34, p<0.01) has been 
reported in older women (Hunter et al., 2014).  
An investigation by Vaikevicius et al. (1993), however, found that the association 
between CRF and PWV tends to strengthen with age as they reported a strong, inverse 
association between CRF and PWV in older adults (r = 0.52, p<0.02), but not in young or 
middle-aged adults (Vaitkevicius, Fleg, Engel, O’Connor, et al., 1993). Additionally, 
based on the participant characteristics provided (community dwelling, predominantly 
white, college educated, and upper-middle-class socioeconomic status), the population in 
the study by Vaitkevicius et al. (1993) is similar to our cohort. Therefore, the associations 
between CRF and PWV in our cohort was inverse, as expected, but slightly weaker 
compared to other studies. 
The slightly weaker association between CRF and PWV in our sample could 
potentially be due to strong associations between covariates (e.g., MAP, BMI) with CRF 
and/or PWV, which weakens the association when these covariates are additionally 
adjusted in more comprehensive regression models. For example, MAP tends to be lower 
with higher CRF, although not significantly different across CRF tertiles in this sample. 
Additionally, MAP was a significant predictor of PWV, with the largest standardized 
parameter estimate, in regression analysis (β = 7.84, p < 0.001) (Table 3). This suggests 
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that MAP explained a large portion of the variance in PWV. This could also potentially 
contribute to why in model 2 the middle CRF tertile had significantly reduced odds of 
high PWV, when the high CRF tertile did not (Table 4). On average, the middle CRF 
tertile had MAP values more like the reference group (lower CRF tertile) than the upper 
CRF tertile did (Table 2). Therefore, similar MAP values may have allowed us to see 
more of a relationship between CRF and PWV in the middle CRF tertile. Also, although 
BMI was not a significant predictor of PWV in regression, it was moderately correlated 
with CRF (r = 0.46, p < 0.001) and was significantly different across CRF tertiles (p < 
0.001) (Table 2). Further, there was an interaction effect between CRF and BMI (p > 
0.05). Thus, when both MAP and BMI were included in the model (in addition to other 
lifestyle factors), the magnitude of the parameter estimate for CRF was almost cut in half 
in our analysis (Table 3). The combination of the strong associations of MAP with PWV 
and BMI with CRF could contribute to the weaker than expected association between 
CRF and PWV. Reduced blood pressure and improved body composition are two major 
benefits of aerobic exercise that are also proposed mechanisms through which aerobic 
exercise may reduce arterial stiffness. Thus, some of the benefits of CRF on PWV may 
also be reflected in these covariates. Other possible explanations may include different 
assessments of CRF (e.g., 400-meter walk test in this study vs. treadmill or bike test in 
other studies) and different sample (e.g., our older adult participants are relatively 
healthier and fitter since participants volunteered to joint this open cohort study).  
While investigating the independence of the relationship between CRF and PWV, 
further adjustment by MS only had a small effect on the parameter estimate of CRF, not 
ruling out the possibility of an association between CRF and PWV independent of MS 
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(model 2 β = 1.74; model 3 β = 1.43) (Table 3). However, the results from the logistic 
regression suggests that the association is not independent of MS; the significant 
reduction in odds of high PWV and significant linear trend after adjusting for potential 
confounders were no longer significant with further adjustment for MS (Table 4). 
There is limited research on the relationship between MS and PWV. An inverse 
relationship between MS and PWV has been shown in young adults (Fahs et al., 2010; 
Roberts et al., 2015), and both an inverse association and no association has been shown 
in older adults (Fahs et al., 2018; Hunter et al., 2014). Our results demonstrate an inverse 
relationship between MS and PWV; as MS increases, PWV decreases (β -0.97 to -1.81, p 
> 0.05) (Table 5). In those studies that found similar associations, there were weak 
correlations (r = -0.11 to -0.23) (Fahs et al., 2010, 2018; Roberts et al., 2015) between 
MS and PWV and moderate correlations (r = 0.32) between MS and large artery elasticity 
(Hunter et al., 2014). However, Fahs et al. (2010) found that the relationship was much 
clearer when comparing MS between high and low arterial stiffness in their sample, 
despite using a lower cut-point for “high PWV” (6.6 m/s determined by cluster analysis). 
Our results follow a similar pattern; there was a very weak correlation between MS and 
PWV (r = -0.10, p = 0.046) and MS was not a significant predictor of PWV in linear 
regression (Table 5). However, there were significantly reduced odds of high PWV with 
higher levels of MS (Table 6). Additionally, one of the other studies that found an inverse 
relationship between MS and PWV looked at the association across BMI categories. 
They found that strong overweight/obese individuals had cardiometabolic profiles more 
similar to normal weight than not strong overweight/obese individuals (Roberts et al., 
2015). Our stratified analysis supports a similar idea; both the middle and upper MS 
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tertiles in the overweight/obese group had significantly reduced odds of high arterial 
stiffness, whereas normal weight group did not (Table 7).  
In contrast to the associations seen between CRF and PWV, when investigating the 
associations between MS and PWV, further adjustment for MAP, BMI, and other 
lifestyle factors only had a small effect on parameter estimate of MS in linear regression, 
compared to the model with only age and sex (model 1 β = -1.81; model 2 β = -1.48). 
Additionally, further adjustment for CRF also had a small effect on the magnitude of the 
MS parameter estimate (model 2 β = -1.48; model 3 β = -0.97) (Table 5). Further, the 
results of the logistic regression suggest an association between high MS and reduced 
odds of high arterial stiffness, independent of CRF (Table 6).  Fahs et al. found that 
relative strength was more strongly related to arterial stiffness than absolute strength or 
lean body mass, suggesting that muscle function is strongly related to arterial stiffness 
(Fahs et al., 2018). While grip strength has been shown to be representative of overall 
muscular strength, it is also a good measure of physical function (Fragala et al., 2016). 
The assessment of muscle function provided by grip strength could potentially contribute 
to the association with PWV, independent of CRF (Table 6).  
Augmentation index is another indicator of arterial stiffness that is thought to reflect 
the condition of both elastic and muscular arteries (Lima-Junior et al., 2018). In our 
additional analyses, we found that CRF was not a significant predictor of augmentation 
index, but MS was inversely related to augmentation index, independent of CRF (p < 
0.026), which is consistent with the findings from logistic regression indicating a stronger 
association of MS than CRF with arterial stiffness.  
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In a larger sample, the Health Aging and Body Composition Study investigated the 
relationship between the 400-meter walk and health outcomes in 3,075 older adults. 
Almost our entire sample falls within their fastest two quintiles (201-303 seconds), and 
the average of our lower CRF tertiles were faster than their cohort’s average (320 
seconds), for both women and men (Table 1) (A. B. Newman et al., 2003; Anne B. 
Newman et al., 2006). While the 400-meter walking test appears to be a valid proxy 
measure of CRF in older adults, our sample may have higher than average fitness and 
could potentially be exhibiting a ceiling effect; the association between CRF and PWV 
may have been stronger if there was a wider range of 400-meter walk times. 
While the exploratory analysis using treadmill test for CRF and chest and leg press 
for MS did not reveal any significant results, most likely due to the smaller sample size 
and case number, it did provide some insight into our proxy measures. The time to 
complete the 400-meter walk in the primary analysis was correlated with PWV(r = 0.19, 
p < 0.001). This, in addition to the strong correlation between 400-meter walk time and 
peak VO2 (r = -0.79) previously reported by Simsonsick et al. (2006), support the use of 
the 400-meter walk in older adults. Overall muscular strength (sex-specific z-scores of 
both chest press and leg press were averaged to find overall muscular strength) and 
overall grip strength (the maximum trials, out of three, for each hand were averaged) 
were moderately correlated (r = 0.41, p < 0.001) in this older adult sample. These results 
suggest that our simple and safe proxy measures for CRF (400-meter walk test) and MS 
(grip strength) provide valid information in our older adult population. 
For both CRF and MS, the multivariable linear and logistic regressions provide 
consistent directions of the relationships. However, the logistic regressions provide 
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statistically significant associations, whereas linear regression did not. Part of this can be 
explained by the nature of these analyses. By dichotomizing outcomes (i.e. “high PWV” 
or “not high PWV”), logistic regression is not weakened by relatively large variations in 
the outcome, like linear regression can be. Therefore, the variety of PWV for a given 
value of CRF or MS affects linear regression more than it does logistic, permitting 
logistic regression to potentially reveal statistically significant associations that were not 
seen in linear regression. Also, results from logistic regression are easier to understand 
and more applicable to real life from a public health perspective, especially in an earlier 
stage of the study to investigate the dose-response relationship between CRF or MS with 
AS.  Logistic regression is particularly useful when examining the combined (joint) 
association of both CRF and MS with AS in this case.    
Overall, the results of this study demonstrate that higher levels of MS, and 
possibly CRF as well, are associated with reduced prevalence of increased (high) arterial 
stiffness in older adults. This provides rationale for further research (longitudinal studies 
and randomized control studies) regarding physical activity and exercise 
recommendations for older adults, for the prevention of CVD. 
 
Combined Associations of Cardiorespiratory Fitness and Muscular Strength 
with Older Adults 
 
 
Although CRF and MS are moderately correlated in this study (r = -0.31, p < 0.001), 
these two physical fitness factors are generally improved by different types of exercise 
(aerobic exercise for CRF and resistance exercise for MS). Therefore, investigating the 
relative importance between CRF and MS on AS in this study is useful to provide 
information to help answer the question “What type or combination of exercise is more 
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effective to prevent CVD?” which is important to develop more comprehensive physical 
activity guidelines.  In the joint analysis, the Fit & Strong group had significantly reduced 
odds of having high PWV compared to the Unfit & Weak reference group. It also had the 
largest reduction in odds (OR, 0.27) out of all the groups (OR, 0.32 and 0.35 for Unfit & 
Strong and Fit & Weak, respectively), however the reduced odds were not significantly 
different between groups. Both the Unfit & Strong and Fit & Weak groups also showed 
similar, and significant, reduced odds of having high PWV (Figure 10). Therefore, the 
most important finding of the joint analysis was that any combination of being fit and/or 
strong was associated with significantly reduced odds of having high PWV, compared to 
the Unfit & Weak group.  
Since we could not find other studies that investigated the combined association 
of CRF and MS on arterial stiffness, we could not directly compare our results. Based on 
the results of our joint analysis with the similar ORs in Unfit & Strong (OR 0.32 [95% CI 
0.13-0.80]) and Fit & Weak (OR 0.35 [0.13-0.93]) groups, the relative contributions of 
CRF and MS appear to be similar. This is further supported by the multivariable linear 
regressions. Although not statistically significant, the linear regressions provide 
standardized parameter estimates for CRF and MS that are of similar magnitude, around 
1.5 standard deviations, specifically in the model adjusted for MAP and lifestyle factors 
(Tables 3 & 5).  
The participant characteristics according to joint analysis grouping also provide 
insight on the similar contributions of CRF and MS (Appendix). The Fit & Strong group 
has, on average, the lowest 400-meter walk time and highest overall grip strength. 
Specifically, Fit & Strong individuals are 10 seconds faster in the 400-meter walk 
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compared to the Fit & Weak group, and have 2.8 kg higher overall grip strength 
compared to the Unfit & Strong group.  
In conclusion, while it appears that the most benefits would be achieved by being 
both fit and strong, older adults will get comparable benefits from physical activity and 
exercise that enhances either fitness or strength. The combined associations of CRF and 
MS with PWV provide novel and important information that could influence how 
physical activity and exercise may be utilized to reduce arterial stiffening, specifically in 
older adults.  
Limitations 
 
 A major limitation of this study is the lack of diversity in the cohort of older 
adults, which is largely white, highly-educated, and living independently. Additionally, 
because of the characteristics of our sample, the 400-meter walk and grip strength 
assessments may not be as sensitive as they would be in a more diverse cohort. There are 
other factors such as eating, hydration status, and room temperature for the assessment of 
PWV. We tried to limit these effects by having participants fast for 12-hours prior to 
assessment, encouraging them to continue drinking water through the fast, and 
completing measurements at the same time of day for all participants. Also, room 
temperature was centrally controlled at a similar level throughout the study. Fortunately, 
the potential effects of these are minimal when comparing PWV between subjects, 
relative to within-subjects comparisons, because of our large sample size. Lastly, since 
this is a cross-sectional analysis, we cannot determine causation. However, this study 
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provides rational and need for further prospective analysis of CRF and MS with arterial 
stiffness in older adults. 
Conclusion 
 
In conclusion, higher levels of both CRF and MS appeared to be associated with a 
lower prevalence of increased (high) arterial stiffness in older adults. To date, there have 
been many studies investigating the relationship between CRF and PWV, and very few 
for MS and PWV. This study expands our knowledge and understanding of the 
independent and combined associations of CRF and MS with AS in older adults. The 
large sample size, “gold-standard” measurement of AS, objective measurements of CRF 
and MS, and unique combined analysis of CRF and MS strengthen our findings. This 
study provides insight on the potential cardiovascular benefits associated with types and 
combinations of exercise for older adults.   
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APPENDIX B. SUPPLEMENTARY MATERIAL 
 
Table 8A. Characteristics of Participants by Combined Categories of Cardiorespiratory Fitness 
and Muscular Strength. 
Characteristic 
Unfit & 
Weak 
Unfit & 
Strong 
Fit &  
Weak 
Fit &  
Strong 
P-value 
n 75 67 66 219  
Age, y 76 (7) 73 (5) 71 (5) 70 (5) 0.003 
Weight, kg 77.1 (16.1) 83.0 (18.5) 73.6 (15.6) 75.7 (14.4) <0.001 
Body mass index, kg/m2 28.3 (4.5) 29.6 (5.5) 27.4 (4.4) 26.5 (4.0) <0.001 
Normal weight, n (%) 20 (27) 13 (20) 21 (32) 78 (36)  
Overweight, n (%) 30 (40) 27 (40) 26 (39) 99 (45)  
Obese, n (%) 25 (33) 27 (40) 19 (29) 42 (19)  
Mean arterial pressure, mmHg 92 (11) 95 (10) 94 (9) 91 (10) 0.055 
Systolic BP, mmHg 135 (15) 135 (16) 132 (14) 129 (13) 0.001 
Diastolic BP, mmHg 74 (8) 77 (9) 76 (8) 75 (8) 0.110 
Hypertensivea, n (%) 37 (49) 35 (52) 30 (45) 80 (37) 0.059 
Pulse Wave Velocityb, m/s 9.4 (1.8) 9.0 (1.7) 8.2 (1.6) 8.2 (1.4) <0.001 
Augmentation Indexc, % 82 (15) 32 (8) 34 (10) 31 (10) 0.207 
Steps per dayc 
4690 
(2007) 
4592 
(2648) 
6454 
(2530) 
6353 
(3396) 
<0.001 
Not meeting physical activity 
guidelinesd, n (%) 
67 (89) 58 (87) 46 (70) 148 (68) <0.001 
Current smoker, n (%) 0 1 (1) 1 (2) 2 (1) 0.760 
Heavy Alcohol Intakee, n (%) 4 (5) 3 (4) 4 (6) 19 (9) 0.572 
Cardiovascular Diseasef, n (%) 6 (8) 6 (9) 6 (9) 5 (2) 0.035 
Low-density lipoprotein 
cholesterol, mg/dl 
102 (33) 102 (28) 107 (30) 109 (29) 0.195 
Hypercholesterolemiag, n (%) 44 (59) 34 (51) 39 (59) 108 (49) 0.353 
400-meter walk time, s 321 (38) 310 (41) 255 (28) 245 (22) <0.001 
Overall grip strengthh, kg 24.7 (7.7) 36.1 (9.8) 26.1 (7.5) 38.9 (11.2) <0.001 
Unless otherwise indicated, values are presented as mean (SD) 
aself-reported: diagnosed hypertension and/or taking blood pressure medication; bcarotid-femoral pulse wave velocity; cpulse 
wave analysis; d < 7500 steps/day; e > 14 drinks/week for men, >7 drinks/week for women; f history of myocardial infarction 
and/or stroke; glow-density lipoprotein cholesterol ≥ 190 mg/dl; hmaximum value (out of 3 trials) from each hand, averaged. 
BP= blood pressure 
 
